Latest News and Press Releases
Want to stay updated on the latest news?
-
Turnstone reports third quarter 2024 financial results and provides recent business highlights
-
Turnstone Biologics presents preclinical data highlighting potential for Selected TIL therapy in solid tumors at SITC 2024
-
Turnstone Biologics announces strategic restructuring to prioritize portfolio and extend financial runway.
-
Dr. Sammy Farah, Turnstone's President and CEO, to present at the 2024 Bank of America Securities Health Care Conference in Las Vegas, NV.
-
Turnstone Biologics appoints biotechnology industry veteran, William Waddill, to its Board of Directors.
-
Turnstone reports fourth quarter and full year 2023 financial results and provides recent business highlights.
-
Dr. Sammy Farah, President and CEO of Turnstone, will participate in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference in New York.
-
Internationally recognized cancer immunotherapy thought leader, Dr. Weber, will help guide Turnstone’s continued advancement of its Selected TIL therapies
-
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing new medicines to treat and cure...